Show simple item record

dc.contributor.authorDe Luca, Ilaria
dc.contributor.authorDi Carlo, Francesco
dc.contributor.authorBurkauskas, Julius
dc.contributor.authorDores, Artemisa R.
dc.contributor.authorCarvalho, Irene P.
dc.contributor.authorGómez-Martínez, M. Ángeles
dc.contributor.authorSzabo, Attila
dc.contributor.authorFujiwara, Hironobu
dc.contributor.authorBarbosa, Cristina Monteiro
dc.contributor.authorDi Nicola, Marco
dc.contributor.authorMazza, Marianna
dc.contributor.authorSani, Gabriele
dc.contributor.authorLuciani, Debora
dc.contributor.authorPettorruso, Mauro
dc.contributor.authordi Giannantonio, Massimo
dc.contributor.authorCataldo, Ilaria
dc.contributor.authorEsposito, Gianluca
dc.contributor.authorMartinotti, Giovanni
dc.contributor.authorZandonai, Thomas
dc.contributor.authorRabin, Olivier
dc.contributor.authorCorazza, Ornella
dc.date.accessioned2024-07-04T08:45:02Z
dc.date.available2024-07-04T08:45:02Z
dc.date.issued2024-06-19
dc.identifier.citationDe Luca , I , Di Carlo , F , Burkauskas , J , Dores , A R , Carvalho , I P , Gómez-Martínez , M Á , Szabo , A , Fujiwara , H , Barbosa , C M , Di Nicola , M , Mazza , M , Sani , G , Luciani , D , Pettorruso , M , di Giannantonio , M , Cataldo , I , Esposito , G , Martinotti , G , Zandonai , T , Rabin , O & Corazza , O 2024 , ' Profiling and assessing the risks of image- and performance-enhancing drugs use during the COVID-19 lockdown ' , Frontiers in Public Health , vol. 12 , 1386721 , pp. 1-12 . https://doi.org/10.3389/fpubh.2024.1386721
dc.identifier.issn2296-2565
dc.identifier.otherJisc: 2084356
dc.identifier.urihttp://hdl.handle.net/2299/28012
dc.description© 2024 The Author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY), https://creativecommons.org/licenses/by/4.0/
dc.description.abstractBackground: Image and Performance-Enhancing Drugs (IPEDs) can enhance mental and physical capabilities and impact one’s overall health. Initially confined in sport environments, IPEDs use has become increasingly widespread in a high-performing society. The present study was aimed at profiling IPEDs use during the COVID-19 lockdown among an international sample of young adults. Methods: A cross-sectional observational study was carried out in eight countries (United Kingdom, Italy, Lithuania, Hungary, Portugal, Spain, Brazil, and Japan) between April and May 2020. The survey questionnaire included validated measurements such as Exercise Addiction Inventory (EAI), Appearance Anxiety Inventory (AAI), and Self-Compassion Scale (SCS) as well as questions about the type of IPEDs, purchasing methods and socio-demographic information. Results: A total of 736 IPEDs users were included in the survey. Their mean age was 33.05 years (±SD = 10.06), and 64.2% were female participants. Overall, 6.8% were found at risk of exercise addiction (EAI >24), 27.6% presented high levels of appearance anxiety, and 24.9% revealed low levels of emotional regulation’s self-compassion. Most participants (55.6%) purchased IPEDs through pharmacies/specialized shops, while 41.3% purchased IPEDs on the Internet. Online IPEDs buyers were mainly men who had higher scores on the Exercise Addiction Inventory. One or more IPEDs classifiable as “potentially risky” were used by 66.3% of the sample. Users of “potentially risky IPEDs” were younger and primarily men. They showed higher scores both on the Exercise Addiction Inventory and Appearance Anxiety Inventory. Conclusion: This study profiled users of IPEDs when the most restrictive COVID-19 lockdown policies were implemented in all the participating countries. More targeted post-COVID 19 prevention strategies should be implemented according to the emerged socio-demographic and psychopathological traits and cross-cultural differences emerged. Longitudinal studies will also be needed to determine the long-term effect of the COVID-19 lockdown on IPEDs consumption.en
dc.format.extent12
dc.format.extent510307
dc.language.isoeng
dc.relation.ispartofFrontiers in Public Health
dc.subjectexercise addiction
dc.subjectpandemic
dc.subjectimage and performance enhancing drugs
dc.subjectCOVID-19
dc.subjectexercise dependence
dc.subjectbody image
dc.titleProfiling and assessing the risks of image- and performance-enhancing drugs use during the COVID-19 lockdownen
dc.contributor.institutionSchool of Life and Medical Sciences
dc.contributor.institutionDepartment of Clinical, Pharmaceutical and Biological Science
dc.contributor.institutionCentre for Future Societies Research
dc.contributor.institutionCentre for Health Services and Clinical Research
dc.contributor.institutionPsychopharmacology, Drug Misuse and Novel Psychoactive Substances Unit
dc.description.statusPeer reviewed
rioxxterms.versionofrecord10.3389/fpubh.2024.1386721
rioxxterms.typeJournal Article/Review


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record